Title : LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer.

Pub. Date : 2020 Nov 2

PMID : 33139730






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Cyclin D1 is one of the most important oncoproteins that drives cancer cell proliferation and associates with tamoxifen resistance in breast cancer. Tamoxifen cyclin D1 Homo sapiens
2 Here, we identify a lncRNA, DILA1, which interacts with Cyclin D1 and is overexpressed in tamoxifen-resistant breast cancer cells. Tamoxifen cyclin D1 Homo sapiens
3 High expression of DILA1 is associated with overexpressed Cyclin D1 protein and poor prognosis in breast cancer patients who received tamoxifen treatment. Tamoxifen cyclin D1 Homo sapiens
4 This study shows the previously unappreciated importance of post-translational dysregulation of Cyclin D1 contributing to tamoxifen resistance in breast cancer. Tamoxifen cyclin D1 Homo sapiens
5 Moreover, it reveals the novel mechanism of DILA1 in regulating Cyclin D1 protein stability and suggests DILA1 is a specific therapeutic target to downregulate Cyclin D1 protein and reverse tamoxifen resistance in treating breast cancer. Tamoxifen cyclin D1 Homo sapiens